Business Standard

Friday, December 20, 2024 | 10:58 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Biological E's Corbevax gets a boost, as govt allows mixing vaccines

Health ministry nod to the Biological E vaccine as 3rd dose after Covishield or Covaxin, CoWIN to be updated within a week

Corbevax gets a boost, as govt allows mixing vaccines
Premium

BE has conducted a multi-centre Phase III placebo-controlled heterologous booster clinical trial in 416 subjects aged 18 to 80 years, who had been vaccinated with two doses of either Covishield or Covaxin at least six months prior to the administrati

Sohini Das Mumbai
The health ministry has approved Biological E’s Covid-19 vaccine Corbevax as the third shot after two doses of Covishield or Covaxin for all adults, clearing the decks for the first heterologous booster in India.

So far, India was using the same vaccine as the third dose or precaution shot (homologous boosting). Countries like the US and Canada have allowed mixing the mRNA vaccines made by Pfizer and Moderna for booster doses.

Government sources on Wednesday confirmed that Corbevax has been approved as the booster shot or third dose after two doses of Covishield (Covid-19 vaccine made by Serum Institute of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in